Tag Archives: GlaxoSmithKline

One to Watch: Q&A with Paul Dyer

By Brittany Agro | Published: December 10, 2009

Paul Dyer, eMedia Director, WeissComm Group (WCG), is already on his way to the top not only on PR News’ 15 to watch list, but also as an emerging leader in the online healthcare landscape. At 26, Paul Dyer has a long list of accolades that most young professionals his age only dream about. As eMedia [...]

Posted in Marketing, People | Also tagged Advertising and Marketing, Health care, Marketing, Mass media, Pfizer, Virgin Megastore, Walgreens | Leave a comment

The Trouble with Transparency

By George Koroneos | Published: November 6, 2009

Guest blog by Jacky Law A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. She always travels first-class and has [...]

Posted in Guest Blog, Strategy | Also tagged Congress, Eli Lilly, Herb Kohl, Medicine, Member of Parliament, United States Senate Committee on Finance, US | Leave a comment

Pharma Celebrates its Own

By Andrew Sheivachman | Published: October 7, 2009

At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]

Posted in Events | Also tagged American Museum of Natural History, business, Clinical trial, Columbia University, Elie Wiesel, Harvard School of Public Health, Health, Health care, Jeffrey Sachs, Pharmaceutical drug, Prix Galien, Public health, United States | Leave a comment

Prix Galien Push for Private/Public Collaboration

By Andrew Sheivachman | Published: October 6, 2009

Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]

Posted in Events | Also tagged Africa, American Museum of Natural History, Harvard School of Public Health, Jeffrey Sachs, Novartis, Prix Galien, Public health, United States | Leave a comment

H1N1 Vaccine Quantities to Fall Short of Predictions

By George Koroneos | Published: August 19, 2009

Image by â– Guerry via Flickr The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday. According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]

Posted in Manufacturing | Also tagged Canada, Health, Influenza, Influenza A virus subtype H1N1, Influenza pandemic, Influenza vaccine | 2 Comments